1. Home
  2. RY vs SYK Comparison

RY vs SYK Comparison

Compare RY & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royal Bank Of Canada

RY

Royal Bank Of Canada

HOLD

Current Price

$158.20

Market Cap

220.4B

Sector

N/A

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$327.51

Market Cap

140.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RY
SYK
Founded
1864
1941
Country
Canada
United States
Employees
100000
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.4B
140.0B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
RY
SYK
Price
$158.20
$327.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$162.00
$429.42
AVG Volume (30 Days)
1.0M
1.9M
Earning Date
02-26-2026
04-30-2026
Dividend Yield
2.80%
1.06%
EPS Growth
N/A
8.25
EPS
N/A
8.40
Revenue
N/A
$25,116,000,000.00
Revenue This Year
$17.12
$9.86
Revenue Next Year
$4.56
$8.39
P/E Ratio
$17.01
$39.58
Revenue Growth
N/A
11.16
52 Week Low
$106.10
$324.93
52 Week High
$176.19
$404.87

Technical Indicators

Market Signals
Indicator
RY
SYK
Relative Strength Index (RSI) 34.74 31.23
Support Level $143.26 N/A
Resistance Level $175.21 $375.26
Average True Range (ATR) 2.30 9.41
MACD -0.28 -2.29
Stochastic Oscillator 0.00 6.92

Price Performance

Historical Comparison
RY
SYK

About RY Royal Bank Of Canada

Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.3 trillion in assets at the end of fiscal 2025. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: